Article info
PDFOriginal article
A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome
- Correspondence to Dr David G Sweet, Neonatal Unit, Royal Maternity Hospital, Grosvenor Road, Belfast, BT12 6BB, Northern Ireland, UK; david.sweet{at}belfasttrust.hscni.net
Citation
A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome
Publication history
- Received January 16, 2017
- Revised March 7, 2017
- Accepted March 9, 2017
- First published May 2, 2017.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/